Skip to content
PubMed This is a summary of 97 peer-reviewed journal articles Updated
Neurology · Autoimmune Cerebellar Ataxia

Autoimmune Cerebellar Ataxia: A Patient Guide

At a Glance

Autoimmune cerebellar ataxia occurs when the immune system attacks the cerebellum, causing balance, coordination, and speech problems. Doctors combine antibody testing, MRI or PET scans, and evaluation for other causes; early immunotherapy may help stabilize symptoms and preserve remaining function.

Autoimmune cerebellar ataxia represents a group of rare conditions where the immune system, which is designed to protect the body, mistakenly identifies the brain’s balance center—the cerebellum—as a threat. The cerebellum is responsible for the fine-tuned coordination of movement, speech, and eye focus; when it comes under immune attack, these functions begin to falter. This can lead to a range of symptoms, from unsteadiness while walking to difficulties with clear speech, often appearing quite suddenly or progressing over several months [1][2].

The underlying cause of this immune response typically falls into one of two main categories. In Primary Autoimmune Cerebellar Ataxia (PACA), the immune system targets the brain without a clearly identifiable external trigger like an infection or a tumor. In contrast, Paraneoplastic Cerebellar Degeneration (PCD) occurs when the immune system attempts to fight a hidden cancer elsewhere in the body but accidentally cross-reacts with the cerebellum because the tumor and the brain share similar proteins. Distinguishing between these two is a high priority, as it determines whether the focus of care should include cancer treatment alongside immune-suppressing therapies [3][4].

Reaching a diagnosis is rarely a single step; instead, it is a “process of exclusion” that relies on a framework of converging evidence. Because many things can cause balance issues—including genetics, vitamin deficiencies, and neurodegenerative diseases—doctors must systematically rule those out first. They then look for specific markers of immune activity, such as antibodies in the blood or spinal fluid, and use advanced imaging like MRI or PET scans to see how the cerebellum is functioning. This collective picture helps your care team move forward with the confidence needed to begin treatment [5][6].

The conceptual idea of ‘cerebellar reserve’ refers to the ability of remaining healthy neurons to compensate for those that have been damaged. Once neurons are lost to a prolonged immune attack, they generally cannot be replaced. Therefore, earlier evaluation and introduction of immunotherapy—medications that calm the immune system—can improve the chance of stabilizing the condition and protecting that reserve [7][8].

While the journey toward diagnosis and treatment can be challenging, understanding the nature of the condition is the first step toward regaining control. By working with a specialized multidisciplinary team, you can ensure that your immune system is managed effectively while prioritizing your long-term mobility and quality of life. Modern medicine continues to refine these treatments, offering clearer pathways for stabilization and support than ever before [9].

Common questions in this guide

What is autoimmune cerebellar ataxia?
Autoimmune cerebellar ataxia is a group of rare disorders in which the immune system mistakenly attacks the cerebellum, the part of the brain that helps control balance and coordination. It can cause unsteadiness, poor coordination, and difficulty speaking clearly.
What is the difference between PACA and PCD?
PACA means the immune system targets the cerebellum without a clearly identified trigger. PCD occurs when an immune response to an underlying cancer cross-reacts with the cerebellum, so evaluation and treatment may include looking for and treating cancer.
How do doctors diagnose autoimmune cerebellar ataxia?
Diagnosis usually combines several types of evidence rather than relying on one test. Doctors rule out other causes of ataxia, check blood or spinal fluid for immune-related antibodies, and may use MRI or PET scans to assess the cerebellum.
What does cerebellar reserve mean?
Cerebellar reserve describes how well healthy cerebellar nerve cells can compensate for cells that have been damaged. Prolonged immune injury can reduce this reserve, and lost neurons generally cannot be replaced.
Can early immunotherapy help autoimmune cerebellar ataxia?
Immunotherapy is used to calm the immune system and may help stabilize the condition. Starting evaluation and treatment earlier can improve the chance of protecting remaining cerebellar function, but the best approach depends on the cause and your overall findings.
Which doctors should coordinate care if PCD is possible?
A multidisciplinary team may be needed, with a neurologist coordinating neurological evaluation and an oncology team assessing for an underlying cancer when appropriate. Ask which clinician will coordinate tests, treatment decisions, and communication across specialties.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Non-specific autoimmune cerebellar ataxia with characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my results so far, do I fall into the category of PACA or PCD?
  2. 2.What is the status of my 'cerebellar reserve'—is there evidence of active inflammation or permanent shrinkage on my scans?
  3. 3.Are we still within the window of opportunity where aggressive immunotherapy is most likely to be effective?
  4. 4.Which specific specialist on my team will be the 'quarterback' coordinating my neurological and oncological care?

References

References (9)
  1. 1

    Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias.

    Hadjivassiliou M, Graus F, Honnorat J, et al.

    Cerebellum (London, England) 2020; (19(4)):605-610 doi:10.1007/s12311-020-01132-8.

    PMID: 32328884
  2. 2

    Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.

    Manto M, Mitoma H

    Brain sciences 2023; (13(12)) doi:10.3390/brainsci13121626.

    PMID: 38137074
  3. 3

    Update on Paraneoplastic Cerebellar Degeneration.

    Loehrer PA, Zieger L, Simon OJ

    Brain sciences 2021; (11(11)) doi:10.3390/brainsci11111414.

    PMID: 34827413
  4. 4

    Anti-Tr/DNER Antibody-Associated Cerebellar Ataxia: a Systematic Review.

    Campana IG, Silva GD

    Cerebellum (London, England) 2022; (21(6)):1085-1091 doi:10.1007/s12311-021-01346-4.

    PMID: 34817790
  5. 5

    Suspected autoimmune cerebellar ataxia: Predictors of immunotherapy response and diagnosis reclassification to neurodegenerative disease.

    Nakamura N, Ii Y, Hirata Y, et al.

    Journal of the neurological sciences 2026; (488()):126048 doi:10.1016/j.jns.2026.126048.

    PMID: 42269360
  6. 6

    FDG-PET in Autoimmune Cerebellar Ataxia: Clinical Correlation and Diagnostic Superiority Over MRI.

    Liu M, Li Q, Mao G, et al.

    Cerebellum (London, England) 2025; (24(5)):130 doi:10.1007/s12311-025-01888-x.

    PMID: 40650847
  7. 7

    Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.

    Mitoma H, Manto M, Hampe CS

    Current neuropharmacology 2019; (17(1)):33-58 doi:10.2174/1570159X16666180917105033.

    PMID: 30221603
  8. 8

    Time Is Cerebellum.

    Mitoma H, Manto M, Hampe CS

    Cerebellum (London, England) 2018; (17(4)):387-391 doi:10.1007/s12311-018-0925-6.

    PMID: 29460203
  9. 9

    Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients.

    Hadjivassiliou M, Martindale J, Shanmugarajah P, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(4)):301-309 doi:10.1136/jnnp-2016-314863.

    PMID: 27965395

This page is for informational purposes only and does not constitute medical advice. Your neurologist and oncology team should interpret your test results and guide decisions about autoimmune cerebellar ataxia.